Cancer, Advanced Clinical Trial
Official title:
The Integrated Support and Palliative in Cancer Day-care Hospital for Patients With Advanced Cancers: Impact on Quality of Life, Care Pathways and Support for Caregivers
Verified date | February 2024 |
Source | Institut Curie |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The main objective is to show the impact on the quality of life (QoL) for adults patients with advanced cancer managed in day hospital of integrated palliative care of cancer center (HDJ-SPI).
Status | Active, not recruiting |
Enrollment | 144 |
Est. completion date | January 23, 2025 |
Est. primary completion date | January 23, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Patient = 18 years old with advanced solid tumor 2. Addressed for the first time to the palliative care team according to current criteria (medico-psycho-social symptoms, progressive risks) 3. With or without anti-cancer treatment 4. With estimated life expectancy of more than 2 months and less than 12 months 5. Able to communicate in French and answer questionnaires 6. Affiliated with a social security system 7. Having signed informed consent, co-signed by the partner if designated by the patient Exclusion Criteria: 1. Patient with primitive brain tumor or malignant hemopathy 2. Severe psychopathological disorders 3. Pregnant patient or childbearing potential without effective method of birth control 4. Unable to be followed at the cancer center until death 5. Patient deprived of liberty or under guardianship - |
Country | Name | City | State |
---|---|---|---|
France | Institut Bergonie | Bordeaux | |
France | Centre Antoine Lacassagne | Nice | |
France | Institutcurie Paris | Paris | |
France | INSTITUT CURIE Saint-Cloud | Saint-cloud | |
France | Institut de Cancerologie de L'Ouest | Saint-herblain | |
France | Centre Paul Strauss | Strasbourg |
Lead Sponsor | Collaborator |
---|---|
Institut Curie |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Analyse impact of hospital day care in integrated palliative care department on quality of life of adult patients with advanced stage cancer | Analyse impact of hospital day care in integrated palliative care department on quality of life of adult patients with advanced stage cancer
Outcome shall be evaluated by assessing Survival without quality of life deterioration,measured by EORTC QLQ-C30 scale with monthly evaluation targeting three dimensions : global quality of life/ fatigue/ patient emotional state |
12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00750178 -
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK0683 in Patients With Advanced Cancer (0683-008)
|
Phase 1 | |
Recruiting |
NCT04028479 -
The Registry of Oncology Outcomes Associated With Testing and Treatment
|
||
Recruiting |
NCT05200572 -
Study of a Behavioral Intervention for Older Advanced Cancer Patients and Their Caregivers
|
N/A | |
Recruiting |
NCT03896958 -
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
|
||
Recruiting |
NCT03383094 -
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
|
Phase 2 | |
Not yet recruiting |
NCT03763396 -
Azoles Targeting Recurrent High Grade Gliomas
|
Early Phase 1 | |
Completed |
NCT01380184 -
Pharmacokinetics of Ridaforolimus (MK-8669) in Chinese Participants (MK-8669-059)
|
Phase 1 | |
Withdrawn |
NCT03123744 -
Histology-Independent Study of Palbociclib in Patients With Advanced Cancer
|
Phase 2 | |
Recruiting |
NCT03452774 -
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
|